4//SEC Filing
Payne Fletcher 4
Accession 0000912282-24-000134
CIK 0000882361other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 6:06 PM ET
Size
5.5 KB
Accession
0000912282-24-000134
Insider Transaction Report
Form 4
Payne Fletcher
SR VP & Chief Fin. Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-02-05+55,000→ 55,000 totalExercise: $2.00Exp: 2034-02-05→ Common Shares (55,000 underlying)
Footnotes (1)
- [F1]50% of the options vest on February 5, 2025, and the remaining options vesting as follows: 1/3 on February 5, 2026; 1/3 on February 5, 2027; and 1/3 on February 5, 2028.
Documents
Issuer
Aptose Biosciences Inc.
CIK 0000882361
Entity typeother
Related Parties
1- filerCIK 0001650476
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 6:06 PM ET
- Size
- 5.5 KB